Contineum Therapeutics Statistics
NASDAQ: CTNMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
8.68-0.36 (-3.98%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Contineum Therapeutics by the numbers
Contineum Therapeutics has a market capitalization of $340.8 million based on 35.35M shares outstanding. With trailing EPS of $-1.77, Contineum Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 18.6% below its 50-day average and 34.6% below its 200-day average.
Average daily trading volume is 776.03K shares, or about $6.7 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CTNM valuation vs. peer median
| Metric | CTNM | Peer median | Difference |
|---|---|---|---|
| Market cap | $340.83M | $343.21M | -1% |
| Avg. volume | 776.03K | 919.30K | -16% |
Peer median across 8 companies: MPLT, INO, LRMR, PEPG, ASPE, AVIR, PBYI, PHAT.
Valuation
- Market cap
- $340.83M
- EPS (TTM)
- $-1.77
- Shares outstanding
- 35.35M
Price and trading
- Previous close
- 9.04
- Open
- 8.87
- Day range
- 8.50 – 9.09
- 52-week range
- 6.73 – 17.79
- 52-week change
- -20.69%
- Beta
- —
- Volume
- 369.21K
- Average volume
- 776.03K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 340.83M
- Forward Pe
- -4.13
- Eps
- -1.77
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 17.79
- Week52 Low
- 6.73
- Avg Volume
- 776.03K
- Shares Outstanding
- 35.35M
- Ma50
- 10.66
- Ma200
- 13.27
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -51.19%
- Pct From52w Low
- 29.07%